A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

PHASE3CompletedINTERVENTIONAL
Enrollment

578

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Bacterial Conjunctivitis
Interventions
DRUG

Gatifloxacin 0.5% eye drops

Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily

DRUG

placebo eye drops

Day 1 = 1 drop of study medication every 2hrs up to 8 times total; day 2-5 = 1 drop twice daily

Trial Locations (1)

Unknown

Gretna

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT00509873 - A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis | Biotech Hunter | Biotech Hunter